NCT00893516Phase 2Terminated
CD4 in Combination With CHOP in Treating Non-cutaneous Peripheral TCell Lymphoma
Study sponsor: Emergent BioSolutions
Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.
Primary completion2008-10Actual
Enrollment · participants5Actual
Source updated2024-04-09Last update listed in the registry record
Version history
Changes to this trial
Pro unlocks the full available history and CSV export. View Pro features
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.